Prelude Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,490
Closed -$320K 1378
2025
Q4
$320K Buy
3,490
+587
+20% +$56.2K 0.02% 756
2025
Q3
$275K Buy
+2,903
New +$273K 0.02% 774
2023
Q4
Sell
-3,597
Closed -$263K 1215
2023
Q3
$263K Sell
3,597
-1,369
-28% -$92.5K 0.02% 743
2023
Q2
$314K Sell
4,966
-1,483
-23% -$86K 0.02% 623
2023
Q1
$379K Sell
6,449
-9,170
-59% -$557K 0.02% 559
2022
Q4
$963K Buy
15,619
+8,860
+131% +$595K 0.05% 393
2022
Q3
$454K Buy
6,759
+2,764
+69% +$175K 0.02% 689
2022
Q2
$245K Buy
+3,995
New +$256K 0.01% 1183
2021
Q1
Sell
-15,033
Closed -$1.05M 1672
2020
Q4
$1.05M Buy
15,033
+4,124
+38% +$257K 0.03% 467
2020
Q3
$560K Buy
+10,909
New +$599K 0.03% 414
2019
Q2
Sell
-8,835
Closed -$654K 1864
2019
Q1
$654K Sell
8,835
-339
-4% -$23.8K 0.04% 430
2018
Q4
$547K Sell
9,174
-1,388
-13% -$112K 0.04% 444
2018
Q3
$997K Buy
10,562
+2,704
+34% +$233K 0.06% 370
2018
Q2
$590K Buy
7,858
+941
+14% +$67.6K 0.04% 482
2018
Q1
$419K Buy
6,917
+100
+1% +$5.41K 0.03% 486
2017
Q4
$318K Buy
+6,817
New +$338K 0.03% 517

Other funds holding HQY

Prelude Capital Management's HQY Position: Q1 2026 in Review

Prelude Capital Management sold out of HealthEquity (HQY) in Q1 2026, closing a stake of 3,490 shares — an estimated $320K sold.

Prelude Capital Management first reported a position in HQY in Q4 2017 and held it in 16 quarters. The position peaked at $1.05M in Q4 2020. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Prelude Capital Management reported no remaining HealthEquity position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 3,490 HealthEquity shares in Q1 2026, an estimated $320K.
  • Prelude Capital Management first reported a position in HealthEquity in Q4 2017 and held it in 16 quarters.
  • Prelude Capital Management's HealthEquity position peaked at $1.05M in Q4 2020.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.